The report "Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021", This report studies the neurovascular devices/interventional neurology market over the forecast period of 2016 to 2021. The market is expected to reach USD 2.62 Billion by 2021 at a CAGR of 8.6% during 2016 to 2021.
Browse 100 market data tables and 52 figures spread through 193 pages and in-depth TOC on "Neurovascular Devices/Interventional Neurology Markert “
http://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html
Early buyers will receive 10% customization on This reports.
A number of factors such as growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, growing market demand for effective neurovascular devices, increasing number of researches in the field of neurovascular therapies, rising demand for minimally invasive neurosurgical procedures, and increasing awareness among neurosurgeons about minimally invasive surgical procedures. However, dearth of skilled neurosurgeons and stringent regulatory policies are the key challenges faced by leading players in the global neurovascular devices/interventional neurology market.
On the basis of products, the neurovascular devices/interventional neurology market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is expected to hold the largest share of the interventional neurology market in 2016. The large market share of this segment can be attributed to the growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.
On the basis of pathology, the neurovascular devices/interventional neurology market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malformations & fistulas, and other diseases. The ischemic strokes segment is expected to hold the largest share of the global neurovascular devices/interventional neurology market in 2016. Dominant market position of ischemic strokes segment is attributed to rising prevalence of ischemic stroke (coupled with exposure of larger proportion of global population to major risk factors such as smoking and diabetes), and increasing patient preference for minimally invasive therapeutic neurosurgical technologies.
On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global interventional neurology market is expected to be dominated by North America. North American region is expected to dominate the neurovascular devices/interventional neurology market during study period owing to significant adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices) and significant medical reimbursement available in the U.S. for neurosurgical procedures.

The Sample Report For This Report@
http://www.marketsandmarkets.com/requestsample.asp?id=847

New product launches and enhancements are the key growth strategies adopted by major players to develop their positions in the global neurovascular devices/interventional neurology market. Moreover, strategies such as agreements and collaborations; strategic acquisitions; and market expansions were also adopted by a significant number of market players to strengthen their product portfolios, distribution networks and expand their geographic presence in the global neurovascular devices/interventional neurology market.
As of 2015, Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), and Terumo Corporation (Japan) are the top four players in the market. Other prominent players present in the market include Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China), among others.
Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=847



About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441